Stock Price
74.26
Daily Change
-0.16 -0.22%
Monthly
7.81%
Yearly
0.20%
Q2 Forecast
72.77

Solventum Corp reported $783M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Abbott USD 3.27B 138M Mar/2026
Align Technology USD 465.34M 23.67M Mar/2026
Baxter International USD 728M 33M Mar/2026
Becton, Dickinson and Co. USD 1.21B 180M Mar/2026
Cencora USD 1.8B 46.42M Dec/2025
Dexcom USD 349.7M 49.8M Mar/2026
Insulet USD 317.2M 14.2M Mar/2026
Solventum Corp USD 783M 24M Mar/2026
West Pharmaceutical Services USD 99.5M 7M Mar/2026
Zimmer Biomet Holdings USD 849.9M 5.8M Mar/2026